RNAi-based screening for synthetic lethal interactions with loss of PTEN in breast cancer identified NUAK1, along with STK11 and PIK3CB, suggesting functional interaction between the LKB1-NUAK1 and PI3K-AKT pathways [69]. This evidence concerns the gene NUAK1 and breast carcinoma.